India’s Chemical Opportunity: Why Chemicals, Why Now?

There are certain sectors where the best time to start looking is when nobody wants to look at them.

Chemicals are one such sector today.

Along with IT, chemicals have been among the more beaten-down parts of the market. The biggest reason has been sustained Chinese oversupply since 2022, which has kept global prices under pressure and hurt the economics of Indian manufacturers.

But chemicals are a cyclical industry.

And that matters.

India’s chemical industry has historically grown at around 4–5% over the long term, but the journey is anything but smooth. The sector goes through multi-year cycles of strong demand,

capacity additions, oversupply, and eventually consolidation.

This creates an interesting setup for investors.

Real wealth is often made by entering a cyclical sector before the cycle turns, not after the earnings recovery is already visible.

The question is: could we be getting close to that point in chemicals?

India is still a small player.

To understand the opportunity, we first need to look at the global picture.

India accounts for only around 2–3% of the global chemical market.

China, on the other hand, accounts for roughly 46%.

And China’s dominance wasn’t built overnight.

Back in 2004, China’s share was closer to 10%. Over the next two decades, it steadily built capacity, integrated supply chains, and captured market share.

China has essentially played a decades-long share-capture game.

India is now trying to capture a small part of that opportunity.

And the numbers can get meaningful very quickly.

Even a 5-percentage-point shift in specialty chemical market share from China to India could represent roughly $8 billion of revenue opportunity.

That’s without assuming that India replaces China.

It simply means taking a small slice of an enormous market.

Why would global customers choose India?

The China+1 story is often presented as a geopolitical narrative.

But there is an economic argument behind it too.

India has a lower labour-cost base than China, and plant construction costs are also competitive.

More importantly, global customers have learned an important lesson over the past few years:

Having the cheapest supplier isn’t always the same as having the safest supply chain.

COVID, trade tensions, and repeated supply disruptions highlighted the risks of depending too heavily on one country.

For many global companies, the objective is therefore not: “Move everything out of China.”

It is: “Don’t depend entirely on China.”

That distinction is important.

Even if China remains the world’s largest chemical producer, global companies have a reason to build alternative sources of supply.

And India is one of the obvious beneficiaries.

But we’ve seen this story before:

This isn’t India’s first chemical opportunity.

Between roughly 2017 and 2022, China itself went through a period of significant disruption.

Pollution crackdowns, winter shutdowns, the 2019 Jiangsu chemical-park explosion, the US-China trade war, and eventually COVID all affected Chinese chemical production.

That created an unusual window for Indian manufacturers.

Global customers started looking for alternatives. Indian capacity expanded.

And investors began pricing in a structural shift in global chemical supply chains.

Indian chemical stocks re-rated sharply during this period.

But then the cycle turned.

From 2022 onwards, Chinese production normalised.

Factories came back online, supply increased, and Chinese companies began competing aggressively in global markets.

The result?

Prices fell. Margins compressed. Capacity utilisation weakened. And the Indian chemical story lost momentum.

This is why the current setup is interesting.

The long-term structural opportunity never disappeared.

Not all chemicals are equal:

This is probably the most important distinction to understand.

When we talk about India’s chemical opportunity, it is easy to put the entire sector into one bucket.

That would be a mistake.

Commodity chemicals:

Commodity chemicals are largely about scale and cost.

Products such as caustic soda and soda ash are produced in large volumes and have relatively little differentiation.

If another producer can make the same product cheaper, customers have little reason to pay you more.

That means: Low differentiation → pricing pressure → thin and cyclical margins.

These businesses can still make money, but their economics are heavily dependent on the industry cycle.

Specialty chemicals:

Specialty and fine chemicals are different.

These are generally produced in smaller volumes but have higher value addition and greater product differentiation.

Think fluorochemicals, agrochemicals, surfactants, electronic chemicals, and pharma/CDMO inputs.

Here, the customer isn’t simply buying a chemical.

They are often buying a specific formulation, quality standard, consistency and reliability.

That creates a different competitive dynamic.

And this is where India is trying to move up the value chain.

The value chain matters:

One simple framework helps explain why some chemical businesses can generate much better economics than others.

Think of the chemical value chain like this:

Raw material → Intermediate → Specialty chemical → End product/application

As you move further down the chain, the product generally becomes more specialised.

And that can mean more value captured by the manufacturer.

This is also why R&D matters.

Between 2012 and 2022, R&D spending across the Indian chemical sector grew faster than revenue.

The direction is clear. Indian companies aren’t simply trying to manufacture more chemicals.

They are trying to develop more complex chemicals and move closer to the end application.

That is where the real opportunity lies.

So, why chemicals, why now?

The answer isn’t that the chemical sector suddenly has a new growth story.

The growth story has been there for years.

What has changed is the starting point.

After several years of Chinese oversupply, weaker margins, and disappointing stock performance, expectations across the sector are much lower.

At the same time, India’s structural advantages remain:

• A relatively low-cost manufacturing base

• Growing R&D capabilities

• Increasing global customer interest in supply-chain diversification

• A large domestic chemical market

• An opportunity to move from intermediates towards higher-value specialty products

The key is timing.

In a cyclical sector, you don’t want to buy the story when everything already looks perfect.

You want to start paying attention when the industry is still dealing with excess capacity, weak pricing, and low expectations, but the conditions for the next upcycle are slowly falling into place.

That’s what makes chemicals worth watching today.

The India chemical story isn’t about replacing China.

It is about taking incremental share from a market where China has built an enormous lead over two decades.

And if India can capture even a small part of that share, particularly in higher-value specialty chemicals, the opportunity could be much larger than the current market perception suggests.